Insight Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Insight Molecular Diagnostics
IMDX Stock   6.85  0.38  5.26%   
Insight Molecular's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Insight Molecular's valuation are provided below:
Gross Profit
2.1 M
Market Capitalization
86.7 M
Enterprise Value Revenue
14.1147
Revenue
3.8 M
Earnings Share
(3.79)
We have found one hundred twenty available fundamental trends for Insight Molecular, which can be analyzed and compared to other ratios and to its competitors. All investors should make sure to confirm all of Insight Molecular regular market performance against the performance between 2010 and 2026 to make sure the company can sustain itself down the road.

Insight Molecular Total Revenue

1.71 Million

Check Insight Molecular financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Insight Molecular's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.4 M, Selling General Administrative of 11.5 M or Other Operating Expenses of 76 M, as well as many indicators such as Price To Sales Ratio of 18.07, Dividend Yield of 0.0015 or Days Sales Outstanding of 239. Insight financial statements analysis is a perfect complement when working with Insight Molecular Valuation or Volatility modules.
  
Build AI portfolio with Insight Stock
Check out the analysis of Insight Molecular Correlation against competitors.

Insight Molecular Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets48.3 M40.3 M37.6 M
Slightly volatile
Short and Long Term Debt Total4.1 M4.2 M3.7 M
Slightly volatile
Other Current Liabilities4.8 M4.3 M3.9 M
Slightly volatile
Total Current Liabilities7.6 M8.4 M6.6 M
Slightly volatile
Property Plant And Equipment Net3.7 M3.2 M2.8 M
Slightly volatile
Accounts Payable2.8 M2.6 M833.7 K
Slightly volatile
Cash12.3 M9.9 M9.2 M
Slightly volatile
Non Current Assets Total32.8 M26.8 M25.2 M
Slightly volatile
Non Currrent Assets Other5.1 M4.9 M3.6 M
Slightly volatile
Cash And Short Term Investments13.8 M9.9 M11.1 M
Slightly volatile
Common Stock Shares Outstanding15.8 M15 M4.4 M
Slightly volatile
Liabilities And Stockholders Equity48.3 M40.3 M37.6 M
Slightly volatile
Other Current Assets1.1 M1.3 M869.4 K
Slightly volatile
Total Liabilities29.2 M54.5 M24.5 M
Slightly volatile
Total Current Assets15.5 M13.5 M12.5 M
Slightly volatile
Short Term Debt1.6 M1.2 M2 M
Slightly volatile
Intangible Assets23.7 M16.8 M17.1 M
Slightly volatile
Common Stock408.4 M389 M151 M
Slightly volatile
Non Current Liabilities Total28.8 M46.1 M18.4 M
Slightly volatile
Net Receivables1.3 M1.9 M641.1 K
Slightly volatile
Capital Lease Obligations2.9 M3.3 M4 M
Slightly volatile
Property Plant And Equipment Gross12.4 M16.1 M9.7 M
Slightly volatile
Short and Long Term Debt1.1 M1.2 M1.3 M
Slightly volatile
Capital Stock329 M389 M276.3 M
Slightly volatile
Non Current Liabilities Other40 M33.9 M65.7 M
Slightly volatile
Net Working Capital3.8 M4 M19.4 M
Slightly volatile

Insight Molecular Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization1.4 M1.8 M1.2 M
Slightly volatile
Selling General Administrative11.5 M15.1 M9 M
Slightly volatile
Other Operating Expenses76 M72.4 M25.8 M
Slightly volatile
Research Development7.2 M11.3 M6.2 M
Slightly volatile
Total Operating Expenses74.6 M71 M25.3 M
Slightly volatile
Interest Expense146.1 K96.6 K100.7 K
Slightly volatile
Selling And Marketing Expenses548.1 K576.9 K1.1 M
Pretty Stable
Cost Of Revenue879.2 K1.3 M682.3 K
Slightly volatile
Total Revenue1.7 M2.2 M1.4 M
Slightly volatile
Reconciled Depreciation2.5 M1.4 M3.7 M
Slightly volatile

Insight Molecular Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation3.7 M2.2 M2.8 M
Slightly volatile
Begin Period Cash Flow12.8 M12.8 M9.8 M
Slightly volatile
Depreciation1.4 M1.8 M1.2 M
Slightly volatile
Capital Expenditures943.3 K593.4 K700.2 K
Slightly volatile
End Period Cash Flow13.6 M11.9 M10.3 M
Slightly volatile
Total Cash From Financing Activities28.7 M23.5 M21.9 M
Slightly volatile
Dividends Paid76.8 K86.4 K94.3 K
Slightly volatile
Issuance Of Capital Stock31.5 M25 M63 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio18.0719.0294.5239
Slightly volatile
Dividend Yield0.00150.00170.0018
Slightly volatile
Days Sales Outstanding239282155
Slightly volatile
Stock Based Compensation To Revenue1.111.173.9466
Pretty Stable
Capex To Depreciation0.280.30.6364
Pretty Stable
EV To Sales15.1815.9892.8152
Slightly volatile
Inventory Turnover2.142.52.5705
Very volatile
Days Of Inventory On Hand151151142
Pretty Stable
Payables Turnover0.550.581.3275
Very volatile
Sales General And Administrative To Revenue13.458.0412.9831
Slightly volatile
Research And Ddevelopement To Revenue6.476.027.204
Slightly volatile
Capex To Revenue0.30.321.0431
Very volatile
Cash Per Share0.720.766.8679
Slightly volatile
Days Payables Outstanding689656419
Slightly volatile
Income Quality0.470.310.5016
Slightly volatile
Intangibles To Total Assets0.270.370.3258
Slightly volatile
Current Ratio2.461.862.018
Pretty Stable
Receivables Turnover1.271.344.3988
Slightly volatile
Capex Per Share0.03380.03550.1833
Pretty Stable
Revenue Per Share0.310.170.3278
Slightly volatile
Interest Debt Per Share0.310.333.1578
Slightly volatile
Debt To Assets0.230.120.2192
Slightly volatile
Operating Cycle283400180
Slightly volatile
Days Of Payables Outstanding689656419
Slightly volatile
Ebt Per Ebit1.111.141.023
Slightly volatile
Effective Tax Rate0.170.160.0753
Slightly volatile
Long Term Debt To Capitalization0.04710.04960.1192
Slightly volatile
Quick Ratio2.451.792.0087
Pretty Stable
Net Income Per E B T1.311.011.2118
Slightly volatile
Cash Ratio1.421.071.4027
Slightly volatile
Days Of Inventory Outstanding151151142
Pretty Stable
Days Of Sales Outstanding239282155
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.830.921.0193
Slightly volatile
Fixed Asset Turnover0.640.610.2712
Slightly volatile
Debt Ratio0.230.120.2192
Slightly volatile
Price Sales Ratio18.0719.0294.5239
Slightly volatile
Asset Turnover0.05070.04830.0257
Slightly volatile

Insight Molecular Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap140.9 M158.5 M173 M
Slightly volatile
Enterprise Value145.4 M163.6 M178.5 M
Slightly volatile

Insight Fundamental Market Drivers

About Insight Molecular Financial Statements

Insight Molecular investors use historical fundamental indicators, such as Insight Molecular's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Insight Molecular. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue5.9 M6.2 M
Cost Of Revenue1.3 M879.2 K
Total Revenue2.2 M1.7 M
Stock Based Compensation To Revenue 1.17  1.11 
Sales General And Administrative To Revenue 8.04  13.45 
Research And Ddevelopement To Revenue 6.02  6.47 
Capex To Revenue 0.32  0.30 
Revenue Per Share 0.17  0.31 
Ebit Per Revenue(37.32)(39.19)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
GOOGAlphabet Inc Class C
VVisa Class A
MSFTMicrosoft

Additional Tools for Insight Stock Analysis

When running Insight Molecular's price analysis, check to measure Insight Molecular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Insight Molecular is operating at the current time. Most of Insight Molecular's value examination focuses on studying past and present price action to predict the probability of Insight Molecular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Insight Molecular's price. Additionally, you may evaluate how the addition of Insight Molecular to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY